title: [Application of novel tyrosine-kinase inhibitors for the treatment of leukemia and Ph-negative myeloproliferative neoplasms].
authors.forename: Keita
authors.initials: K
authors.lastname: Kirito
mesh_terms: D000818:Animals; D064127:Aurora Kinases; D002986:Clinical Trials as Topic; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors
chemical_list: C497970:FLT3 protein, human; D011505:Protein-Tyrosine Kinases; D051941:fms-Like Tyrosine Kinase 3; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases